The article discusses Jim Cramer's views on Nvidia's market behavior and the broader implications for investors. Despite strong financial performance, the stock fell due to high expectations. Cramer suggests diversifying portfolios beyond tech stocks to mitigate risks. Vertex Pharmaceuticals Inc.